{{Rsnum
|rsid=13223993
|Gene=IGFBP3
|Chromosome=7
|position=45911631
|Orientation=plus
|GMAF=0.3099
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 34.5 | 57.5
| HCB | 9.5 | 46.0 | 44.5
| JPT | 11.5 | 32.7 | 55.8
| YRI | 23.1 | 53.1 | 23.8
| ASW | 24.6 | 50.9 | 24.6
| CHB | 9.5 | 46.0 | 44.5
| CHD | 14.7 | 40.4 | 45.0
| GIH | 1.0 | 25.7 | 73.3
| LWK | 26.4 | 48.2 | 25.5
| MEX | 8.8 | 31.6 | 59.6
| MKK | 23.7 | 48.1 | 28.2
| TSI | 11.8 | 30.4 | 57.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19786971
|Title=Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents
}}

{{PMID Auto
|PMID=19938081
|Title=Altered transmission of HOX and apoptotic SNPs identify a potential common pathway for clubfoot
|OA=1
}}

{{PMID|19240240|OA=1
}} IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.

{{PMID|19603096|OA=1
}} An analysis of growth, differentiation and apoptosis genes with risk of renal cancer.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}